Phoenix Biotech Correlations
| PBAXWDelisted Stock | 0.06 0.0001 0.16% |
The current 90-days correlation between Phoenix Biotech Acqu and Marblegate Acquisition Corp is 0.01 (i.e., Significant diversification). The correlation of Phoenix Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Phoenix Biotech Correlation With Market
Good diversification
The correlation between Phoenix Biotech Acquisition and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Phoenix Biotech Acquisition and DJI in the same portfolio, assuming nothing else is changed.
Phoenix |
Moving together with Phoenix Stock
| 0.68 | JPHLF | Japan Post Holdings | PairCorr |
| 0.61 | MZHOF | Mizuho Financial | PairCorr |
| 0.62 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
Moving against Phoenix Stock
| 0.43 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.37 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.37 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.36 | BKRKY | Bank Rakyat | PairCorr |
| 0.36 | PBCRY | Bank Central Asia | PairCorr |
| 0.36 | PTBRY | Bank Negara Indonesia | PairCorr |
| 0.31 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
Related Correlations Analysis
| -0.27 | -0.33 | -0.22 | -0.26 | GATEW | ||
| -0.27 | 0.43 | 0.48 | -0.23 | PCCTW | ||
| -0.33 | 0.43 | -0.01 | 0.22 | HWELW | ||
| -0.22 | 0.48 | -0.01 | -0.23 | ENTFW | ||
| -0.26 | -0.23 | 0.22 | -0.23 | ROSEW | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Phoenix Stock performing well and Phoenix Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Phoenix Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GATEW | 1.38 | 0.12 | 0.00 | 0.30 | 0.00 | 2.94 | 30.95 | |||
| PCCTW | 16.80 | 6.86 | 0.42 | 5.52 | 9.14 | 20.00 | 490.25 | |||
| HWELW | 10.02 | 1.43 | 0.11 | 0.37 | 9.39 | 42.86 | 99.63 | |||
| ENTFW | 12.76 | 2.38 | 0.11 | (0.52) | 13.52 | 37.50 | 82.83 | |||
| ROSEW | 24.91 | 3.17 | 0.22 | 0.19 | 22.11 | 48.24 | 320.11 |
Delisting Warning - PBAXW
Phoenix Biotech Acqu was delisted
| The entity Phoenix Biotech Acquisition with a symbol PBAXW was delisted from NASDAQ Exchange. Please try CERo Therapeutics Holdings with a symbol CEROW from now on. Check all delisted instruments accross multiple markets. |
Still Interested in Phoenix Biotech Acquisition?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.